» Articles » PMID: 24535840

Is Low Iron Status a Risk Factor for Neural Tube Defects?

Overview
Publisher Wiley
Date 2014 Feb 19
PMID 24535840
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Folic acid supplements can protect against neural tube defects (NTDs). Low folate and low vitamin B12 status may be maternal risk factors for having an NTD affected pregnancy. However, not all NTDs are preventable by having an adequate folate/ B12 status and other potentially modifiable factors may be involved. Folate and vitamin B12 status have important links to iron metabolism. Animal studies support an association between poor iron status and NTDs, but human data are scarce. We examined the relevance of low iron status in a nested NTD case-control study of women within a pregnant population-based cohort.

Methods: Pregnant women were recruited between 1986 and 1990, when vitamin or iron supplementation in early pregnancy was rare. Blood samples, taken at an average of 14 weeks gestation, were used to measure ferritin and hemoglobin in 64 women during an NTD affected pregnancy and 207 women with unaffected pregnancies.

Results: No significant differences in maternal ferritin or hemoglobin concentrations were observed between NTD affected and nonaffected pregnancies (case median ferritin 16.9 µg/L and hemoglobin 12.4 g/dl versus 15.4 µg/L and 12.3g/dl in controls). As reported previously, red cell folate and vitamin B12 concentrations were significantly lower in cases. Furthermore, there was no significant association of iron status with type of NTD lesion (anencephaly or spina bifida).

Conclusion: We conclude that low maternal iron status during early pregnancy is not an independent risk factor for NTDs. Adding iron to folic acid for periconceptional use may improve iron status but is not likely to prevent NTDs.

Citing Articles

Determinants of neural tube defects among women who gave birth in hospitals in Eastern Ethiopia: evidence from a matched case control study.

Berhane A, Belachew T BMC Womens Health. 2023; 23(1):662.

PMID: 38071290 PMC: 10710723. DOI: 10.1186/s12905-023-02796-0.


Pathogenesis of neural tube defects: The regulation and disruption of cellular processes underlying neural tube closure.

Engelhardt D, Martyr C, Niswander L WIREs Mech Dis. 2022; 14(5):e1559.

PMID: 35504597 PMC: 9605354. DOI: 10.1002/wsbm.1559.


Micronutrient imbalance and common phenotypes in neural tube defects.

Kakebeen A, Niswander L Genesis. 2021; 59(11):e23455.

PMID: 34665506 PMC: 8599664. DOI: 10.1002/dvg.23455.


High levels of iron supplementation prevents neural tube defects in the Fpn1 mouse model.

Stokes B, Sabatino J, Zohn I Birth Defects Res. 2016; 109(2):81-91.

PMID: 28008752 PMC: 5388561. DOI: 10.1002/bdra.23542.

References
1.
Zohn I, De Domenico I, Pollock A, Ward D, Goodman J, Liang X . The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease. Blood. 2007; 109(10):4174-80. PMC: 1885502. DOI: 10.1182/blood-2007-01-066068. View

2.
Kirke P, Molloy A, Daly L, Burke H, Weir D, Scott J . Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med. 1993; 86(11):703-8. View

3.
Hoyle C, Henderson D, Matthews D, Copp A . Transferrin and its receptor in the development of genetically determined neural tube defects in the mouse embryo. Dev Dyn. 1996; 207(1):35-46. DOI: 10.1002/(SICI)1097-0177(199609)207:1<35::AID-AJA4>3.0.CO;2-X. View

4.
Shaw G, Carmichael S, Yang W, Selvin S, Schaffer D . Periconceptional dietary intake of choline and betaine and neural tube defects in offspring. Am J Epidemiol. 2004; 160(2):102-9. DOI: 10.1093/aje/kwh187. View

5.
Zohn I, Sarkar A . The visceral yolk sac endoderm provides for absorption of nutrients to the embryo during neurulation. Birth Defects Res A Clin Mol Teratol. 2010; 88(8):593-600. DOI: 10.1002/bdra.20705. View